Ahmed Hassan
Practicing in Cairo, Egypt · Arabic, English, French
ABOUT
CREDENTIALS
Doctor of Medicine (MD)
Cairo University Faculty of Medicine, 2006
✓ Verified
Fellowship in Pulmonary & Critical Care Medicine
Ain Shams University Hospital, 2010
✓ Verified
Certification in Interventional Pulmonology
Egyptian Board of Pulmonary Medicine, 2013–2028
✓ Verified
CASE EVIDENCE
Case · anonymized
I consulted with a 58-year-old man with severe COPD who was experiencing frequent exacerbations despite maximal inhaler therapy. After reviewing his regimen, I recommended adjustments including adding roflumilast and optimizing his inhaler technique, which reduced his exacerbation frequency by over 60% within four months. Verified by Rebirthealth.
Case · anonymized
I advised a 35-year-old woman with treatment-resistant asthma who had been hospitalized three times in one year. My assessment identified her as a candidate for biologic therapy targeting IL-5, and after coordinating with her local team to initiate treatment, she remained hospitalization-free for over 14 months. Verified by Rebirthealth.
Case · anonymized
I provided a second opinion for a 62-year-old patient diagnosed with idiopathic pulmonary fibrosis who was uncertain about starting antifibrotic medication. I explained the evidence for nintedanib, addressed his concerns about side effects, and helped him make an informed decision to begin treatment early, which has helped stabilize his lung function. Verified by Rebirthealth.
PLATFORM HISTORY
CLIENT FEEDBACK
23 of 26 clients marked this advisor's work as "what they hoped for"
“Dr. Hassan explained my COPD management options with exceptional clarity. He identified gaps in my treatment that my local doctors had missed, and his recommendations made a real difference in my daily breathing.”
— Client, Respiratory Care, Q3 2024
“His knowledge of the latest asthma biologics was invaluable. He helped me understand which treatment pathway was right for my specific type of asthma and guided me through the entire process with patience.”
— Client, Treatment Guidance, Q1 2025